Portal de Periódicos da CAPES

Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time

2022; American Society for Microbiology; Volume: 13; Issue: 1 Linguagem: Inglês

10.1128/mbio.03442-21

2161-2129

María Mora González López Ledesma, Lautaro Sánchez, Diego Ojeda, Santiago Oviedo Rouco, Andrés H. Rossi, Augusto Varese, Ignacio Mazzitelli, Carla A. Pascuale, Esteban A. Miglietta, Pamela Elizabeth Rodríguez, Horacio M. Pallarés, Guadalupe S. Costa Navarro, Julio J. Caramelo, Paul W. Rothlauf, Zhuoming Liu, Louis-Marie Bloyet, Marjorie Cornejo Pontelli, Natalí B. Rasetto, Shirley D. Wenker, Lila Y. Ramis, Magalí G. Bialer, María José de Leone, Carlos Esteban Hernando, Luciana Bianchimano, Antonella S. Ríos, María Soledad Treffinger Cienfuegos, Diana Rosa Rodríguez Garcia, Yésica Longueira, Natalia Laufer, Diego E. Álvarez, Ana Ceballos, Valeria Ochoa, Cecilia Monzani, Gariela Turk, Melina Salvatori, Jorge Carradori, Katherine Prost, Alejandra Rima, Claudia Varela, Regina Ercole, Rosana Toro, Sebastián Gutiérrez, Martín Zubieta, Dolores Acuña, Mercedes Soledad Nabaes Jodar, Carolina Torres, Laura Mojsiejczuk, Mariana Viegas, Pilar Velazquez, Clarisa Testa, Nicolás Kreplak, Marcelo J. Yanovsky, Sean P. J. Whelan, Jorge Geffner, Marina Pífano, Andrea V. Gamarnik,

Vaccine Coverage and Hesitancy

Vaccines have been produced in record time for SARS-CoV-2, offering the possibility of halting the global pandemic. However, inequalities in vaccine accessibility in different regions of the world create a need to increase international cooperation.